ZEB1 and breast cancer: Of note, in EMT-activated BC cells, the immune checkpoint ligand PD-L1 was shown to be up-regulated in a Zeb-1–dependent manner (Noman et al., 2017), reinforcing the evidence that EMT-associated gene signatures correlate with increased inflammatory immune cell infiltration toward BC aggressiveness (Mak et al., 2016).